| P2093 | author name string | Joachim W Thüroff | |
| | Walburgis Brenner | |
| | Jonas Welter | |
| | Dirk Prawitt | |
| | Thorsten Enklaar | |
| | Annette Hasenburg | |
| | Sebastian Frees | |
| | Heide-Katharina Bauer | |
| | Ines Breuksch | |
| P2860 | cites work | The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region | Q22010498 |
| | Loss of tumor suppressor protein PTEN during renal carcinogenesis. | Q53390981 |
| | Reference genes for gene expression analysis by real-time reverse transcription polymerase chain reaction of renal cell carcinoma. | Q54338989 |
| | Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth | Q79249861 |
| | Oncologic long-term outcome of elective nephron-sparing surgery versus radical nephrectomy in patients with renal cell carcinoma stage pT1b or greater in a matched-pair cohort | Q82820786 |
| | Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN | Q83130882 |
| | Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase | Q22253438 |
| | Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function | Q24295164 |
| | The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 |
| | Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN | Q24322051 |
| | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
| | PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration | Q24677034 |
| | PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 |
| | Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 |
| | The functions and regulation of the PTEN tumour suppressor | Q29615536 |
| | PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways | Q31837554 |
| | Ligand binding to integrins | Q33912940 |
| | NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN. | Q35256204 |
| | Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma | Q36375196 |
| | Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis | Q36998831 |
| | New insights into PTEN. | Q37011116 |
| | Mitochondrial translocation of cofilin is required for allyl isothiocyanate-mediated cell death via ROCK1/PTEN/PI3K signaling pathway | Q37071666 |
| | PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling | Q37116576 |
| | PTEN and the PI3-kinase pathway in cancer | Q37259680 |
| | Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways | Q37425090 |
| | PTEN function: the long and the short of it. | Q38198345 |
| | Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling | Q38916214 |
| | SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane | Q39328325 |
| | Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas | Q40000796 |
| | The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration | Q40002542 |
| | Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer | Q40325176 |
| | Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. | Q40587498 |
| | Alternative splicing of the human PTEN/MMAC1/TEP1 gene | Q40836678 |
| | Differential inhibition of renal cancer cell invasion mediated by fibronectin, collagen IV and laminin | Q40878251 |
| | Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade | Q41549055 |
| | Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma. | Q41758134 |
| | High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor | Q41857468 |
| | Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. | Q42807109 |
| | Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo | Q45134010 |
| | Integrin α5 triggers the metastatic potential in renal cell carcinoma | Q47140682 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | renal cell carcinoma | Q1164529 |
| P304 | page(s) | 35 | |
| P577 | publication date | 2018-06-28 | |
| P1433 | published in | Cell Communication and Signaling | Q1254390 |
| P1476 | title | In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself. | |
| P478 | volume | 16 | |